Intracoronary Administration of Microencapsulated HGF in a Reperfused Myocardial Infarction Swine Model

Therapy microencapsulation allows minimally invasive, safe, and effective administration. Hepatocyte growth factor (HGF) has angiogenic, anti-inflammatory, anti-apoptotic, and anti-fibrotic properties. Our objective was to evaluate the cardiac safety and effectiveness of intracoronary (IC) administr...

Descripción completa

Detalles Bibliográficos
Autores principales: Blanco-Blázquez, Virginia, Báez-Díaz, Claudia, Sánchez-Margallo, Francisco Miguel, González-Bueno, Irene, Martín, Helena, Blázquez, Rebeca, Casado, Javier G., Usón, Alejandra, Solares, Julia, Palacios, Itziar, Steendam, Rob, Crisóstomo, Verónica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960949/
https://www.ncbi.nlm.nih.gov/pubmed/36826582
http://dx.doi.org/10.3390/jcdd10020086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960949/
https://www.ncbi.nlm.nih.gov/pubmed/36826582
http://dx.doi.org/10.3390/jcdd10020086

Ejemplares similares